Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects
Completed · Phase 1
Conditions studied: Healthy
In brief
Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.
Key facts
- Study ID
- NCT00856219
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 12
- Starts
- 2009-02-01
- Expected to finish
- 2011-03-01
- Last updated by the study team
- 2015-05-22
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- General good health as demonstrated by medical history, physical\& laboratory tests
- Age between 18 and 40 years
- Written informed consent prior to the performance of any study related procedures
You may not qualify if…
- History of cancer, rheumatoid arthritis, or immunological, renal, hepatic, endocrine, neurologic, heart disease or hypertension
- Any medication taken in past 48 hrs (except birth control)
- Recent history of alcohol or drug abuse
- Unable to provide written informed consent
- Exposure to any experimental agent or procedure within 30 days of study
- Pregnant or breast-feeding
Where it is running
- Rutgers-RWJMS — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.